Germany Faces ‘Long Road Ahead’ in Covid Battle, Expert Warns
(Bloomberg) -- Germany has a long battle ahead against the Covid-19 pandemic, a top health official warned, with pressure set to increase on intensive-care units even as infections show signs of peaking.
An apparent plateau in the number of new cases could partly be a result of overwhelmed local health authorities falling behind on testing, Lothar Wieler, the president of the RKI public-health institute, said Friday at a news conference in Berlin. He urged citizens to reduce social contacts and called for caution in interpreting the latest Covid data.
“We still have a long road ahead of us,” said Wieler, who was flanked by outgoing German Health Minister Jens Spahn. “It's far too early to say we have reached a turning point, let alone forgo tougher measures, quite the opposite.”
Germany's infection rate declined for three straight days this week before rising slightly again to 442.1 on Friday, a level Wieler described as “still much too high.”
With a fourth wave of the virus sweeping across the country, Chancellor Angela Merkel and her incoming successor Olaf Scholz on Thursday agreed with Germany's 16 regional premiers on stricter nationwide curbs for people who aren't vaccinated and paved the way to making Covid shots compulsory.
Only people who are inoculated or recovered will be allowed into restaurants, theaters and non-essential stores, while the vaccine mandate will go to a vote in the lower house of parliament in coming weeks.
Read more: Germany's Scholz Sets 30 Million-Shot Goal to Start His Term
Scholz said he expects the measure to pass, and Merkel -- who is stepping aside from politics next week -- said she also supports it.
“This decision came late -- unfortunately for many, too late,” Spahn said Friday in reference to the new curbs. “But at least the decision was made.”
Scholz's Social Democrats are set to announce Spahn's replacement on Monday, with Karl Lauterbach -- a professor of medicine who has taught at the Harvard School of Public Health -- one of the candidates tipped to get the job.
| Read our QuickTake explainers: |
|---|
©2021 Bloomberg L.P.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
